Cargando…
Our Current Understanding of the Heterogeneity in Prostate Cancer and Renal Cell Carcinoma
Urological cancer is a collective term for cancers of the bladder, kidney, ureter, penis, prostate, and testicles. Last year, more than 444,000 people were diagnosed with urinary cancers in the United States. In this review, we talk about the complexity of prostate and kidney cancer.
Autores principales: | Zhu, Sha, Chen, Junru, Zeng, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962000/ https://www.ncbi.nlm.nih.gov/pubmed/36836061 http://dx.doi.org/10.3390/jcm12041526 |
Ejemplares similares
-
The current status of renal cell carcinoma and prostate carcinoma grading
por: Delahunt, Brett, et al.
Publicado: (2018) -
The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first‐line therapy for patients with metastatic castration‐resistant prostate cancer
por: Wang, Zhipeng, et al.
Publicado: (2021) -
Hormone refractory prostate cancer: Current understanding and future perspectives
por: Khochikar, Makarand
Publicado: (2007) -
New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer
por: Chlosta, Piotr L., et al.
Publicado: (2017) -
Understanding and targeting prostate cancer cell heterogeneity and plasticity
por: Tang, Dean G.
Publicado: (2022)